Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) FCF Margin (2020 - 2025)

Biofrontera has reported FCF Margin over the past 6 years, most recently at 14.12% for Q4 2025.

  • For Q4 2025, FCF Margin fell 634.0% year-over-year to 14.12%; the TTM value through Dec 2025 reached 32.13%, down 459.0%, while the annual FY2025 figure was 32.14%, 459.0% down from the prior year.
  • FCF Margin for Q4 2025 was 14.12% at Biofrontera, up from 54.15% in the prior quarter.
  • Over five years, FCF Margin peaked at 2.11% in Q2 2022 and troughed at 229.05% in Q4 2021.
  • A 5-year average of 59.31% and a median of 42.64% in 2023 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: tumbled -22095bps in 2021 and later soared 14749bps in 2022.
  • Year by year, FCF Margin stood at 229.05% in 2021, then surged by 64bps to 81.56% in 2022, then dropped by -3bps to 83.64% in 2023, then surged by 91bps to 7.78% in 2024, then crashed by -81bps to 14.12% in 2025.
  • Business Quant data shows FCF Margin for BFRI at 14.12% in Q4 2025, 54.15% in Q3 2025, and 34.34% in Q2 2025.